Latest filing published 31 Aug 2026 for Cogent Biosciences, Inc., €203k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Arlene Morris is a declared insider at 5 companies (board member); the most frequent names are Affymax Inc, Palatin Technologies Inc and Cogent Biosciences, Inc. Between 4 September 2007 and 27 August 2026, the trades on record add up to 206 filings.
In open-market terms, that means 6 purchases worth €24k on one side and 159 sales worth €13.6M on the other. Taken together, the sales exceed the purchases by €13.6M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 15 share grants and 26 option exercises. 2026 to date brings no purchases and 2 sales.
Half of the purchases are above €658 and half below. 5 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
Most recently, on 31 August 2026, the filings show an open-market sale worth €1.3M in Cogent Biosciences, Inc. The clock since the last published purchase (2 July 2021) now reads 1,940 days. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations